|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 09, 2018 ) "The global pen needles market estimated to grow at a CAGR of 4.6% during the forecast period from 2018 to 2025. The market for Pen needles was valued at USD 1,603.8 Mn in 2017 and is estimated to reach US$ 2,280.6 Mn by 2025. The global pen needles market is segmented on the basis of type, therapy, and length and geography. On the basis of type, the market is segmented into standard pen needles and safety pen needles. On the basis of therapy, the market is segmented into insulin therapy, GLP-1 therapy and growth hormone therapy. Based on length, the global pen needles market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm.
The pen needles market is aimed to describe, define and estimate the forecast for market size of the pen needles till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global pen needles market. The market report for pen needles is appropriate to cater the needs and demands of various stakeholders that include manufacturers, distributors and suppliers of pen needles, public and private hospitals, academic medical centers and teaching hospitals, privately practicing physicians and surgeons, medical institutes, research centers and other academic hostilities, pharmacies, ambulatory surgical centers and other distribution channels.
Get Sample Copy at: http://bit.ly/2NPLQ6v
Key Players:
The major players operating in the market of pen needles include BD, Novo Nordisk A/S, YPSOMED AG, B. Braun Melsungen AG, Owen Mumford, Ltd., HTL-Strefa S.A., Ultimed, Inc., Terumo Corporation, Allison Medical, Inc., and Artsana S.p.A. among others. The global pen needles market is highly competitive and driven by large number of novel product launches and approvals. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes introduced Dispovan insulin pen needle which is the first made-in-India disposable pen needle that is technologically efficient and affordable than that of the currently available products in the market.
According to the International Diabetes Federation (IDF) Europe, in 2017, there were 7.476.800 cases of diabetes in Germany. Moreover, approximately 270,000 new cases are recorded in Germany each year. This is expected to drive the market for overall pen needles in this country. On the other hand, Asia Pacific is expected to witness significant growth in the market owing to factors such as increasing focus of market players developing novel products at affordable prices, developing healthcare infrastructure and massive pool of diabetic prevalent population.
Table of Content:
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Pen Needles Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Pen Needles Market By Type
3.2.2 Pen Needles Market By Therapy
3.2.3 Pen Needles Market By Length
3.2.4 Pen Needles Market By Region
3.2.4.1 By Countries
3.3 PEST Analysis
3.3.1 North America PEST Analysis
3.3.2 Europe PEST Analysis
3.3.3 Asia Pacific PEST Analysis
3.3.4 Middle East and Africa PEST Analysis
3.3.5 South and Central America PEST Analysis
Inquire about this Report at http://bit.ly/2R3zKVc
Reason to Buy:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the surgical scalpel market.
-Highlights key business priorities in order to assist companies to realign their business strategies.
-The key findings and recommendations highlight crucial progressive industry trends in the global surgical scalpel market, thereby allowing players across the value chain to develop effective long-term strategies.
-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
The Insight Partners
Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
